期刊文献+

环氧合酶-2在胰腺癌组织中的表达及其意义 被引量:5

Expression and Significance of Cyclooxygenase-2 in Human Pancreatic Carcinomas
下载PDF
导出
摘要 背景与目的:非甾体类抗炎药物(nonsteroidalanti-inflammatorydrugs,NSAIDs)可以预防或降低消化系统肿瘤的发病率,提示环氧合酶-2(cyclooxygenase-2,COX-2)的表达与消化系统肿瘤的发生、发展密切相关。本研究通过检测胰腺癌组织中COX-2的表达,探讨COX-2与bcl-2表达的关系,及其在胰腺癌发生、发展过程中的作用。方法:胰腺癌等组织COX-2和bcl-2的表达采用ABC免疫组化分析;评价两者表达及其与患者临床病理特征的关系。结果:胰腺癌组织COX-2和bcl-2的表达阳性率分别为73.3%和66.7%,阳性率明显高于胰腺良性病变组织和正常胰腺组织,两者呈高度正相关,相关系数r=0.470(P<0.01)。但COX-2表达率与患者临床病理特征无关(P>0.05)。结论:胰腺癌组织中COX-2表达增强,COX-2表达与bcl-2表达有协同效应,两者共同参与胰腺癌细胞凋亡的调控。 BACKGROUND &OBJECTIVE:Nonsteroidal anti-inflammatory drug s (NSAIDs )reduced the incidence of g astrointe stinal neoplasms with inhibition of cyclooxyg enase-2(COX-2).This study was desig ned to investig ate the expression and sig nificance of C OX-2and the relationship between CO X-2and bcl-2in human pancreatic carcin oma.METHODS :COX-2and bcl-2expression was determined with ABC i mmunohistochemical analysis in the samples of pancreatic carcinoma.RESULTS :COX-2and bcl-2proteins were found in 22of 30(73.3%)and 20of 30(66.7%)patients with pancreatic carcinoma,which were hig her than th ose with pancreatic benig n disease a nd normal pancreas,respectively(P<0.05).There was positive correlation bet ween the expression rates of COX-2and bcl -2in pancreatic carcinoma.The corr elation coefficient was 0.470(P<0.01).There was no sig nificant differenc e in expression rates of COX-2in patient s among ag e,sex,tumor location,tum or size,histolog ical deg ree,and TNM s tag ing(P>0.05).CONCLUSION:COX-2protein is overexpressed in human pa ncreatic carcinoma.The co-express ion of COX-2and bcl-2mig ht play an importa nt role in the reg ulation of apoptosi s of pancreatic carcinoma cells.
出处 《癌症》 SCIE CAS CSCD 北大核心 2003年第6期649-652,共4页 Chinese Journal of Cancer
关键词 环氧合酶-2 胰腺癌 细胞凋亡 非甾体类抗炎药物 BCL-2蛋白 病理特征 Pancreatic neoplasms Cyclooxyg enase Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献2

  • 1蔡德巍,中华病理学杂志,1994年,23卷,100页
  • 2Lu Q,J Phathol,1993年,19卷,431页

共引文献1

同被引文献50

  • 1王蔚.抗癌药Bortezomib[J].药学进展,2004,28(8):385-385. 被引量:1
  • 2张双红,朱萱.早期食管癌诊断研究进展[J].国外医学(肿瘤学分册),2003,30(6):450-452. 被引量:13
  • 3Eberhart CE,Coffey RJ,Radhika A,et al.Upregulayion of cycloo-xygenase-2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology,1994,107(2):1183~1188.
  • 4Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apotosis induced by Fas,Bax,caspases,and anticancerdrugs.Cancer Res,1998,58(23):5315~5320.
  • 5Krysan K,Merchnt FH,Zhu L,et al.Cox-2-dependent stabilization of survivin in non-small cell lung cancer.FASEB,2004,18(1):206~208.
  • 6Xiong H Q, Abbruzzese J L,Lin E, et al. NF-κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells [ J ]. Inter J Cancer,2003,108 ( 10 ) : 181-188.
  • 7Doi Ryuichiro, Fujimoto Koji, Wada M, et al. Current status of adjuvant therapy for pancreatic cancer [ J ]. Gan To Kagaku Ryoho,2002,29 (3) :370-375.
  • 8Kuba K, Matsumoto K, Ohnishi K,et al. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells [ J ]. Biochem Biophys Res Commun,2000,279(7) :846-852.
  • 9Mitsuhiko Murakami, Eishi Nagai, Kazuhiro Mizumoto, et al. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice[J], Int Cancer,2005 117(1) : 160-165.
  • 10Kindler H L, Friberg G, Stadler W M,et al. Bevacizumab (B) plus gemcitabine (G) in patients (pts) with advanced pancreatic cancer (PC) : Updated results of a multicenter phase II trial[J]. Clin Oncol,2004,22(14) : 4009.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部